- Home
- ALTG vs DRUG Comparison
ALTG vs DRUG Comparison
Compare ALTG & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTG
- DRUG
- Stock Information
- Founded
- ALTG 1984
- DRUG 2019
- Country
- ALTG United States
- DRUG United States
- Employees
- ALTG N/A
- DRUG N/A
- Industry
- ALTG Industrial Machinery/Components
- DRUG Pharmaceuticals and Biotechnology
- Sector
- ALTG Industrials
- DRUG Health Care
- Exchange
- ALTG Nasdaq
- DRUG Nasdaq
- Market Cap
- ALTG 268.0M
- DRUG 260.6M
- IPO Year
- ALTG N/A
- DRUG N/A
- Fundamental
- Price
- ALTG $6.70
- DRUG $38.03
- Analyst Decision
- ALTG Buy
- DRUG Buy
- Analyst Count
- ALTG 4
- DRUG 1
- Target Price
- ALTG $15.75
- DRUG $75.00
- AVG Volume (30 Days)
- ALTG 223.4K
- DRUG 169.6K
- Earning Date
- ALTG 11-12-2024
- DRUG 02-11-2025
- Dividend Yield
- ALTG 3.46%
- DRUG N/A
- EPS Growth
- ALTG N/A
- DRUG N/A
- EPS
- ALTG N/A
- DRUG N/A
- Revenue
- ALTG $1,900,000,000.00
- DRUG N/A
- Revenue This Year
- ALTG $1.98
- DRUG N/A
- Revenue Next Year
- ALTG $2.46
- DRUG N/A
- P/E Ratio
- ALTG N/A
- DRUG N/A
- Revenue Growth
- ALTG 6.51
- DRUG N/A
- 52 Week Low
- ALTG $5.40
- DRUG $0.93
- 52 Week High
- ALTG $13.67
- DRUG $79.02
- Technical
- Relative Strength Index (RSI)
- ALTG 41.78
- DRUG 48.12
- Support Level
- ALTG $6.97
- DRUG $36.35
- Resistance Level
- ALTG $7.62
- DRUG $43.40
- Average True Range (ATR)
- ALTG 0.31
- DRUG 4.14
- MACD
- ALTG -0.14
- DRUG -0.49
- Stochastic Oscillator
- ALTG 6.38
- DRUG 12.81
About ALTG Alta Equipment Group Inc.
Alta Equipment Group Inc is an integrated equipment dealership platform in the U.S. Its segments are Material Handling and Construction Equipment. The Material Handling segment is engaged in operations related to the sale, service, and rental of lift trucks in Michigan, Illinois, Indiana, New York, Virginia, and throughout the New England states whereas, the Construction Equipment segment is principally engaged in operations related to the sale, service, and rental of construction equipment in Michigan, Indiana, Illinois, Ohio, New York, Florida and throughout the New England States.
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.